Resultados de la búsqueda 71-80 of 11963 for Dulaglutide

1. Bispecific antibody therapy

   Bispecific antibody therapy uses medicines that target diseases in two ways at the same time. It uses specially designed, lab-made proteins called bispecific ...

2. Hematología - Ensayos clínicos - Mayo Clinic

   ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

3. Tumor cerebral

   Childhood central nervous system germ cell tumors treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/brain/patient/child ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these ...

5. Hematología - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

6. Mayo Clinic Digestive Diseases Physician Update e-Edition, June 2015

   Bile acid malabsorption (BAM)) occurs in about 1 in 3 patients with IBS-D and up to 50 percent of those with functional diarrhea, yet it remains underdiagnosed.

7. Hematología - Ensayos clínicos - Mayo Clinic

   ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

8. Hematología - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

9. Mayo Clinic PM&R Physician Update - October 2025

   Page 1.

10. Hematología - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...